OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

CFO exercised or converted 5,262 HIMS derivative securities | OQRO

Home
Insider trades
Hims & Hers Health
CFO exercised or converted 5,262 HIMS derivative securities

Insider trades

Insider trade

CFO exercised or converted 5,262 HIMS derivative securities

Traded Feb 3, 2026 · Filed Feb 4, 2026

HIMHims & Hers HealthHIMS

5,262
Shares · @ $5.01

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 3, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 4, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001907056-26-000006

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Feb 4, 2026, 9:13 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Hims & Hers Health, Inc.

Issuer CIK

1773751

Ticker

HIMS

Reporting person

Oluyemi Okupe

Relationship

Officer

Officer title

Chief Financial Officer

Security

Class A Common Stock

Table

Non-derivative (Table I)

Transaction date

Feb 3, 2026

Transaction code

Shares / units

5,262

Price per share

$5.01

Acquired / disposed

Acquired (A)

Shares owned after

96,879

Ownership form

Direct

Amendment

Footnotes from the filing

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Around the same time

Soleil Boughton (Chief Legal Officer) sold ~$71K of Hims & Hers Health

Scheduled in advanceFiled 7mo ago

Oluyemi OkupeChief Financial Officer

Filed 7mo ago

411KShares

Traded Feb 23 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record

Soleil BoughtonChief Legal Officer

Filed 7mo ago

274KShares

Traded Feb 23 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.

More Official record